Launched in 2019, Dewpoint is based on the work of Anthony Hyman, a researcher who was part of the team that discovered biomolecular condensates. Shape-shifting blobs, these condensates form inside cells and can contain proteins and other molecules. Researchers have started to explore how condensates affect chemical reactions in the cell and potentially play a role in disease.
Dewpoint is one of several biotechnology companies attempting to create new treatments through studying condensates. While Dewpoint is working across several different therapeutic areas, its metabolic research is what drew the attention of Novo, the pharma company that sells the in-demand diabetes drug Ozempic.
The partnership will focus on the discovery of small molecule drugs to treat insulin resistance and diabetic complications. The companies claim that undoing the dysregulation of condensates could help forestall development of insulin resistance, which is a key factor in Type 2 diabetes. READ MORE
by Delilah Alvarado
Source: biopharmadive.com
CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform. The planned investment consists of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions.
DSM-Firmenich has announced the sale of its MEG-3 fish oil business to KD Pharma Group, a contract development and manufacturing organisation that is active in pharmaceutical and nutritional lipids. As part of the transaction, DSM-Firmenich will obtain a minority stake of 29% in KD Pharma’s parent company O³ Holding GmbH.
Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutica l and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer. Cécile will join the executive team and assume responsibility for business development, marketing, project management, commercial operations, and product management.